| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| F1DAM3 | G protein-coupled receptor 27; | GPR27; | NP_061844.1; | 375 | human |
| A0A024R2D4 | ADP-ribosylation factor-like 8B, isoform CRA_b; | ARL8B; | NULL | 186 | human |
| A2RRC6 | ZFHX2 protein; Zinc finger homeobox protein 2; | ZFHX2; | NULL | 408 | human |
| B8ZZB3 | Coiled-coil domain-containing protein 141; Uncharacterized protein; | CCDC141; FLJ39502; | NULL | 652 | human |
| Q6ICK5 | Em:AC008101.5 protein; HCG1998895; | Em:AC008101.5; | NULL | 212 | human |
| A5H1P5 | Potassium voltage-gated channel subfamily E member 4; Potassium voltage-gated channel, Isk-related family, member 4; cDNA, FLJ93702, highly similar to Homo sapiens potassium voltage-gated channel, Isk-related family, member 4 (KCNE4), mRNA; | KCNE4; | NP_542402.3; | 170 | human |
| D3DRL4 | HCG2011315, isoform CRA_a; | NULL | NULL | 138 | human |
| A0A024R208 | Blocked early in transport 1 homolog (S. cerevisiae)-like, isoform CRA_a; Fragment; | BET1L; | NULL | 178 | human |
| Q9UI81 | PRO0159; Putative uncharacterized protein PRO0159; | PRO0159; | NULL | 83 | human |
| A0A024R9Q1 | Thrombospondin 1, isoform CRA_a; | THBS1; | NULL | 1170 | human |
| A0A059QHV3 | NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3; | ND3; | NULL | 115 | human |
| A0A024R9Q5 | Tyrosine-protein kinase receptor; EC 2.7.10.1; | LTK; | NULL | 475 | human |
| A0A024R209 | Transient receptor potential cation channel, subfamily M, member 1, isoform CRA_a; | TRPM1; | NULL | 1532 | human |
| C3U3A0 | DUX4; Double homeodomain protein DUX4-fl; | DUX4; | NP_001280727.1; | 424 | human |
| E7EPW2 | 28S ribosomal protein S25, mitochondrial; | MRPS25; | NULL | 110 | human |
| D6W5H0 | HCG1776413, isoform CRA_a; | NULL | NULL | 192 | human |
| F8VVU7 | Monocarboxylate transporter 2; | SLC16A7; | NULL | 84 | human |
| C9JU85 | E3 ubiquitin-protein ligase CBL-B; Fragment; | CBLB; | NULL | 139 | human |
| B4DLC8 | Signal transducer and activator of transcription 2; cDNA FLJ59331, highly similar to Signal transducer and activator of transcription 2; | STAT2; | NULL | 460 | human |
| A0A024RBX8 | Adaptor-related protein complex 1, sigma 2 subunit, isoform CRA_d; | AP1S2; | NULL | 199 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |